Disc Medicine (IRON) surges 32% premarket ahead of Phase 3 APOLLO trial data
FROM THE WIRE · GURUFOCUS.COM
On October 19, 2026, Disc Medicine Inc (NASDAQ: IRON) saw its shares jump 32% in premarket trading as investors eagerly await the topline data from its pivotal
Read at the source ↗MARKET IMPACTNEUTRAL✦ News Impact agent estimateTone: expected bullishThe premarket surge reflects investor anticipation of pivotal biotech trial data.AI-generated summary
✦ IN BRIEF · AIAI-generated summary
- 01Disc Medicine shares jumped 32% in premarket trading on October 19, 2026.
- 02Investors are awaiting topline data from its pivotal Phase 3 APOLLO trial.
- 03The stock is listed on NASDAQ under the ticker IRON.
NEWS IMPACT AND MARKET REACTIONChange since the story · reference
Impact and summary are estimates by the News Impact AI agent, not financial advice.Open in Markets